Actively Recruiting
Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions
Led by University Hospital, Toulouse · Updated on 2026-03-25
20
Participants Needed
1
Research Sites
101 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Diagnostic wandering is one of the characteristics of endometriosis due to great anatomical and clinical variability but also due to poorly relevant diagnostic examinations. \[18F\]-FES PET/CT could on the one hand improve diagnosis by showing greater sensitivity than MRI and on the other hand make it possible to quantify and characterize the expression of ER from diagnosis and thus helping to guide therapeutic care. We will thus attempt to correlate the intensity of \[18F\]-FES PET/CT with the expression of estrogen receptors and the intensity of pain.
CONDITIONS
Official Title
Use of a New Diagnostic Tool in the Detection and Characterization of Endometriosis Lesions
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female patients aged over 18 years
- Patients treated surgically for painful symptoms related to endometriosis with a pain score (VAS) of 4 or higher
- Patients treated surgically for endometriosis in the context of infertility with a pain score (VAS) less than 4
- Patients who have provided informed consent
- Patients who underwent a preoperative MRI and have no contraindication for [18F]-FES PET/CT
- Patients scheduled for surgery at mid-cycle
- Patients affiliated to a social security scheme
You will not qualify if you...
- Patients treated for endometriosis without surgery
- Pregnant patients
- Patients currently taking hormone therapy
- Menopausal patients
- Patients with hypersensitivity to Fluoroestradiol (18F) or any excipients
- Patients under legal protection
- Claustrophobic patients
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Toulouse, Rangueil Hospital
Toulouse, France, 65360
Actively Recruiting
Research Team
A
Ariane Weyl
CONTACT
C
Caroline Peyrot
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here